These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12230621)

  • 1. Can the reverse transcriptase-polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen improve staging and predict biochemical recurrence?
    Adsan O; Cecchini MG; Bisoffi M; Wetterwald A; Klima I; Danuser HJ; Studer UE; Thalmann GN
    BJU Int; 2002 Oct; 90(6):579-85. PubMed ID: 12230621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy.
    Okegawa T; Nutahara K; Higashihara E
    BJU Int; 1999 Jul; 84(1):112-7. PubMed ID: 10444137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
    Thomas J; Gupta M; Grasso Y; Reddy CA; Heston WD; Zippe C; Dreicer R; Kupelian PA; Brainard J; Levin HS; Klein EA
    J Clin Oncol; 2002 Aug; 20(15):3213-8. PubMed ID: 12149293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer.
    Okegawa T; Noda H; Kato M; Miyata A; Nutahara K; Higashihara E
    Prostate; 2000 Aug; 44(3):210-8. PubMed ID: 10906737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular staging by RT-pCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer.
    Mitsiades CS; Lembessis P; Sourla A; Milathianakis C; Tsintavis A; Koutsilieris M
    Clin Exp Metastasis; 2004; 21(6):495-505. PubMed ID: 15679047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
    Gao CL; Maheshwari S; Dean RC; Tatum L; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
    Urology; 1999 Apr; 53(4):714-21. PubMed ID: 10197846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
    Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
    Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy.
    de la Taille A; Olsson CA; Buttyan R; Benson MC; Bagiella E; Cao Y; Burchardt M; Chopin DK; Katz AE
    Int J Cancer; 1999 Aug; 84(4):360-4. PubMed ID: 10404086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
    Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
    Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
    Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
    J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
    Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
    Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific membrane antigen mRNA in blood as a potential predictor of biochemical recurrence after radical prostatectomy.
    Joung JY; Cho KS; Chung HS; Cho IC; Kim JE; Seo HK; Chung J; Park WS; Choi MK; Lee KH
    J Korean Med Sci; 2010 Sep; 25(9):1291-5. PubMed ID: 20808671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy.
    Yates DR; Rouprêt M; Drouin SJ; Comperat E; Ricci S; Lacave R; Sèbe P; Cancel-Tassin G; Bitker MO; Cussenot O
    Prostate; 2012 Sep; 72(12):1382-8. PubMed ID: 22228175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.
    Olsson CA; de Vries GM; Raffo AJ; Benson MC; O'Toole K; Cao Y; Buttyan RE; Katz AE
    J Urol; 1996 May; 155(5):1557-62. PubMed ID: 8627821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM
    Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
    Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
    Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
    Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.